The U.S. Can't Ignore Europe's Unscientific
The U.S. Can't Ignore Europe's Unscientific Regulations
America's economy is increasingly intertwined with the European Union's, and unfortunately the litany of bad European imports hasn't ended with Russell Brand. Today, Brussels bureaucrats increasingly subject chemicals to the guillotine of fact-challenged, agenda-driven science. And while we have yet to see how Trump will execute his campaign pledges on trade, one thing is certain: the United States can no longer ignore Europe’s proposed unscientific restrictions of safe and economically important substances used in countless everyday products.
One of the most egregious examples is a proposal by France to classify titanium dioxide, a naturally occurring pigment crucial to myriad products from paints to pharmaceuticals to sunscreen, as a carcinogen. Titanium dioxide has been safely used in products for over a century—it replaced dangerous lead components as a white pigment in paints and is one of the safest substances used in sunscreens to absorb the sun’s UV rays and protect against skin cancer.
Certainly, materials posing a threat to human health should be appropriately regulated. But the French case against titanium dioxide has no scientific basis.
Studies following thousands of industrial workers reveal no increased mortality from cancer, even after decades of intense titanium dioxide exposure. Titanium dioxide also hasn’t been shown to cause cancer in animals, with the exception of rats exposed under extreme “overload” conditions – akin to what one might experience chronically breathing a thick cloud of dust. In fact, European Chemicals Agency guidelines recommend against giving significant weight to such “overload” studies because similar effects are unlikely to be seen in humans.
Classifying titanium dioxide as a carcinogen would severely limit its use in most applications, creating serious consequences for the U.S. The substance is used in a vast volume of products both exported to and imported from the EU, and in most cases there are no available substitutes.
The bad science doesn’t stop there. The EU’s environmental arm is considering nominating the substance octamethylcyclotetrasiloxane (D4) as a Persistent Organic Pollutant (POP).
These terms probably mean nothing to most readers, but D4 is an essential material used in the creation of virtually all silicone products. Once a material is classified as a “POP” they are severely restricted and phased out of use. This extreme action is reserved for chemicals that persist in the environment and can travel over long distances. However, the overwhelming weight of scientific evidence shows that D4 tends to degrade rather than persist in the environment and doesn’t travel.
The EU’s “environmental champions” overlook the fact that silicone chemistry is crucial to the production of solar panels, windmills, and energy efficient buildings. By empowering renewables, D4 saves over 9 times the carbon dioxide emissions used to produce it. Ironically, eliminating D4’s use through a POP designation could have long-term environmental impacts.
In another scientifically questionable move, the European Commission recently unveiled its proposal for a haphazard system to identify chemicals as “endocrine disruptors” without actually confirming whether named substances can actually harm the human endocrine system.
A wide array of naturally occurring and man-made substances can interact with the human endocrine system, including sunlight, soy, and caffeine. Instead of drafting criteria to restrict only chemicals that show evidence they have enough potency to harm the human endocrine system, the EU is moving toward a broad, hazard-based approach.
The U.S. Environmental Protection Agency has a solution of its own – the Endocrine Disruptor Screening Program. Rather than issuing a blanket rejection of any chemical showing endocrine activity, the EPA integrates hazard and risk to determine whether restrictions are warranted, and provides a gradation of regulatory responses appropriate to the level of exposure.
With our own models for chemical regulation already in place, the U.S. needs to flex its muscles over poorly proposed regulations streaming from across the pond to ensure Europe bases its decisions on sound scientific evidence to protect American consumers.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....
Continue Reading
Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...
Continue Reading
A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...
Continue Reading
Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...
Continue Reading
A blockchain partnership can sound like confetti until the plumbing matters. This one at least points at a real commercial choke point: Asian-originated tokenized assets need deeper pools of global onchain capital, while global networks need credible asset supply and institutional access. HashKey Group's HSK Chain and Coinbase-built Base say they intend to tackle both...
Continue Reading
Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...
Continue Reading
Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...
Continue Reading
Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...
Continue Reading
A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...
Continue Reading
GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...
Continue Reading
Top 5 Most Recently Viewed Articles
RAMM Pharma Corp. Explores Strategic Sale Options RAMM Pharma Corp. (CSE: RAMM), along with its wholly owned subsidiaries, is considering the sale of its subsidiary, Canapar Corp., and its industrial facility situated in Italy. This strategy aligns with the Company’s goal of enhancing operational efficiency and focusing on growth avenues in the cannabinoid industry....
Continue Reading
Marquis Software Solutions Faces Data Breach Concerns Recently, Marquis Software Solutions, a notable software and services provider, faced a serious incident regarding a data breach that may have compromised the personal information of many individuals. This breach raised significant concerns for anyone whose data might have been affected. Details of the Cybersecurity...
Continue Reading
Understanding the GSK Securities Class Action Lawsuit Investors in GSK plc (NYSE: GSK) now find themselves presented with a significant opportunity to participate in a class action lawsuit. This legal action is initiated on behalf of purchasers of American Depositary Receipts (ADRs) from a defined Class Period. The relevant dates for this lawsuit span from early in 2020...
Continue Reading
Strengthening Cybersecurity in Entertainment with CYPFER In an era where digital security is paramount, CYPFER is leading the charge to develop comprehensive cybersecurity strategies tailored for the film and entertainment industry. The company has formed a partnership with iconic filmmaker Michael Bay, known for his blockbuster hits that captivate audiences worldwide....
Continue Reading
Chris Hall Steps in as Chief Product Officer at IRIS Software Group Pivotal leadership appointment will accelerate product innovation and delivery of AI-first strategy IRIS Software Group, a renowned global provider of accounting, HR, payroll, and education software, has announced a significant enhancement to its leadership team with the appointment of Chris Hall as Chief...
Continue Reading